LS-102
CAS No. 1456891-34-1
LS-102( ——— )
Catalog No. M38018 CAS No. 1456891-34-1
LS-102 is a selective E3 ubiquitin ligase synoviolin (Syvn1) inhibitor. LS-102 inhibits the autoubiquitination of synoviolin with an IC50 of 35 μM. LS-102 has the potential for rheumatoid arthritis treatment.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 103 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 271 | In Stock |
|
| 50MG | 423 | In Stock |
|
| 100MG | 609 | In Stock |
|
| 200MG | 854 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLS-102
-
NoteResearch use only, not for human use.
-
Brief DescriptionLS-102 is a selective E3 ubiquitin ligase synoviolin (Syvn1) inhibitor. LS-102 inhibits the autoubiquitination of synoviolin with an IC50 of 35 μM. LS-102 has the potential for rheumatoid arthritis treatment.
-
DescriptionLS-102 is a selective E3 ubiquitin ligase synoviolin (Syvn1) inhibitor.
-
In VitroCell Viability Assay Cell Line:Rheumatoid synovial cells (RSCs) m Concentration:20, 40, 60 μM Incubation Time:12 hours Result:Inhibited proliferation of RSCs with an IC50 of 5.4 μM.
-
In VivoAnimal Model:7-week-old DBA/1 male mice (CIA model) Dosage:1.3, 4.0 mg/kg Administration:I.p.; daily for 4 weeks Result:Reduced the clinical severity scores.
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1456891-34-1
-
Formula Weight452.6
-
Molecular FormulaC24H36N8O
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (220.95 mM )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Baccatin III
Baccatin III is an isolate of the Pacific yew tree (Taxus brevifolia) and related species. Baccatin III is a precursor to the anti-Y drug paclitaxel (Taxol).
-
Parimifasor
Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).
-
(Pyr5,N-Me-Phe8,Sar9...
[Glp5,(Me)Phe8,Sar9] Substance P (5-11) (DiMe-C7) is a Substance P analogue that has approximately the same effects as Substance P on neurokinin 1 receptor (NK1R) in rat brain, but with a much longer duration of action. [Glp5,(Me)Phe8,Sar9] Substance P (5-11) selectively activates dopamine metabolism in the mesencephalon and midbrain cortex of the rat brain. [Glp5,(Me)Phe8,Sar9] Substance P (5-11) also increases motor activity and induces recovery of addictive agent-seeking behavior in rats.
Cart
sales@molnova.com